Isabel Burghardt

574 total citations
16 papers, 453 citations indexed

About

Isabel Burghardt is a scholar working on Molecular Biology, Oncology and Genetics. According to data from OpenAlex, Isabel Burghardt has authored 16 papers receiving a total of 453 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Molecular Biology, 8 papers in Oncology and 6 papers in Genetics. Recurrent topics in Isabel Burghardt's work include TGF-β signaling in diseases (8 papers), Glioma Diagnosis and Treatment (6 papers) and Cancer Cells and Metastasis (5 papers). Isabel Burghardt is often cited by papers focused on TGF-β signaling in diseases (8 papers), Glioma Diagnosis and Treatment (6 papers) and Cancer Cells and Metastasis (5 papers). Isabel Burghardt collaborates with scholars based in Switzerland, Germany and Sweden. Isabel Burghardt's co-authors include Michael Weller, Patrick Roth, Emese Szabó, Elisabeth J. Rushing, Brigitte Frank, Ghazaleh Tabatabai, Wolfgang Wick, Christiane A. Opitz, Felix Tritschler and Dorothee Gramatzki and has published in prestigious journals such as The Journal of Immunology, JNCI Journal of the National Cancer Institute and Oncogene.

In The Last Decade

Isabel Burghardt

16 papers receiving 450 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Isabel Burghardt Switzerland	11	210	127	122	92	64	16	453
Yong-Kil Hong South Korea	15	234 1.1×	166 1.3×	255 2.1×	151 1.6×	56 0.9×	24	519
Ana Angulo‐Urarte Spain	11	339 1.6×	112 0.9×	107 0.9×	92 1.0×	43 0.7×	12	636
Wei‐Hsiu Liu Taiwan	15	350 1.7×	211 1.7×	101 0.8×	209 2.3×	65 1.0×	44	720
José Lastiri Argentina	14	210 1.0×	204 1.6×	88 0.7×	76 0.8×	27 0.4×	22	539
Yolanda Piña United States	13	255 1.2×	127 1.0×	89 0.7×	134 1.5×	36 0.6×	62	629
Yoshie Yasui Japan	11	155 0.7×	85 0.7×	211 1.7×	104 1.1×	49 0.8×	19	408
Ondřej Kalita Czechia	12	347 1.7×	123 1.0×	190 1.6×	215 2.3×	55 0.9×	31	595
Meiqing Lou China	13	287 1.4×	92 0.7×	69 0.6×	131 1.4×	48 0.8×	32	501
Raita Fukaya Japan	9	148 0.7×	114 0.9×	106 0.9×	91 1.0×	93 1.5×	19	502
Taiji Tohyama Japan	12	236 1.1×	161 1.3×	123 1.0×	62 0.7×	87 1.4×	37	732

Countries citing papers authored by Isabel Burghardt

Since Specialization

Citations

This map shows the geographic impact of Isabel Burghardt's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Isabel Burghardt with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Isabel Burghardt more than expected).

Fields of papers citing papers by Isabel Burghardt

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Isabel Burghardt. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Isabel Burghardt. The network helps show where Isabel Burghardt may publish in the future.

Co-authorship network of co-authors of Isabel Burghardt

This figure shows the co-authorship network connecting the top 25 collaborators of Isabel Burghardt. A scholar is included among the top collaborators of Isabel Burghardt based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Isabel Burghardt. Isabel Burghardt is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

16 of 16 papers shown

Burghardt, Isabel, et al.. (2022). Prognostic Relevance of Transforming Growth Factor-β Receptor Expression and Signaling in Glioblastoma, Isocitrate Dehydrogenase-Wildtype. Journal of Neuropathology & Experimental Neurology. 81(3). 225–235. 2 indexed citations

Burghardt, Isabel, et al.. (2021). A tumor-promoting role for soluble TβRIII in glioblastoma. Molecular and Cellular Biochemistry. 476(8). 2963–2973. 10 indexed citations

Burghardt, Isabel, et al.. (2021). Endoglin and TGF-β signaling in glioblastoma. Cell and Tissue Research. 384(3). 613–624. 12 indexed citations

Wirsching, Hans‐Georg, Manuela Silginer, Will Macnair, et al.. (2020). Negative allosteric modulators of metabotropic glutamate receptor 3 target the stem-like phenotype of glioblastoma. Molecular Therapy — Oncolytics. 20. 166–174. 5 indexed citations

Schittenhelm, Jens, Jan Sperveslage, Michel Mittelbronn, et al.. (2020). FGFR3 overexpression is a useful detection tool for FGFR3 fusions and sequence variations in glioma. Neuro-Oncology Practice. 8(2). 209–221. 9 indexed citations

Joncour, Vadim Le, Maija Hyvönen, Minna Holopainen, et al.. (2019). Vulnerability of invasive glioblastoma cells to lysosomal membrane destabilization. EMBO Molecular Medicine. 11(6). 42 indexed citations

Seystahl, Katharina, Isabel Burghardt, Hannah Schneider, et al.. (2017). Biological Role and Therapeutic Targeting of TGF-β3 in Glioblastoma. Molecular Cancer Therapeutics. 16(6). 1177–1186. 45 indexed citations

Papa, Eleanna, et al.. (2017). Negative control of the HGF/c-MET pathway by TGF-β: a new look at the regulation of stemness in glioblastoma. Cell Death and Disease. 8(12). 3210–3210. 34 indexed citations

Weller, Michael, Patrick Roth, Felix Sahm, et al.. (2017). Durable Control of Metastatic AKT1-Mutant WHO Grade 1 Meningothelial Meningioma by the AKT Inhibitor, AZD5363. JNCI Journal of the National Cancer Institute. 109(3). 1–4. 53 indexed citations

10.

Weller, Michael, Will Macnair, Katja Eschbach, et al.. (2017). TGF-β induces oncofetal fibronectin that, in turn, modulates TGF-β superfamily signaling in endothelial cells. Journal of Cell Science. 131(1). 32 indexed citations

11.

Weller, Michael, et al.. (2017). Cutting Edge: ERK1 Mediates the Autocrine Positive Feedback Loop of TGF-β and Furin in Glioma-Initiating Cells. The Journal of Immunology. 198(12). 4569–4574. 16 indexed citations

12.

Seystahl, Katharina, Isabel Burghardt, Hannah Schneider, et al.. (2016). P01.02 Biological role and therapeutic targeting of TGF-β3 in glioblastoma. Neuro-Oncology. 18(suppl_4). iv18–iv18. 7 indexed citations

13.

Kunze, Jens, Isabel Burghardt, Michael Weller, et al.. (2015). Computer-assisted quantification of motile and invasive capabilities of cancer cells. Scientific Reports. 5(1). 15338–15338. 20 indexed citations

14.

Silginer, Manuela, Isabel Burghardt, Dorothee Gramatzki, et al.. (2015). The aryl hydrocarbon receptor links integrin signaling to the TGF-β pathway. Oncogene. 35(25). 3260–3271. 51 indexed citations

15.

Krishnan, Shanmugarajan, Emese Szabó, Isabel Burghardt, et al.. (2015). Modulation of cerebral endothelial cell function by TGF-β in glioblastoma: VEGF-dependent angiogenesis versus endothelial mesenchymal transition. Oncotarget. 6(26). 22480–22495. 54 indexed citations

16.

Burghardt, Isabel, Felix Tritschler, Christiane A. Opitz, et al.. (2007). Pirfenidone inhibits TGF-β expression in malignant glioma cells. Biochemical and Biophysical Research Communications. 354(2). 542–547. 61 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact